Suspended

Caesarean Delivery With or Without an Indwelling Bladder Catheter

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Without placement of indwelling catheter

+ With placement of indwelling catheter

Procedure
Who is being recruted

Urogenital Diseases+4

+ Female Urogenital Diseases and Pregnancy Complications

+ Infections

Over 18 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Interventional
Study Start: June 2019
See protocol details

Summary

Principal SponsorUniversity of Aarhus
Study ContactHelle F Bungum, MDMore contacts
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2019

Actual date on which the first participant was enrolled.

Protokol version 2\_13092018 Scientific protocol Caesarean delivery with or without an indwelling bladder catheter. A randomised trial. Background In 2015, approximately 20% of all pregnant women gave birth by caesarean delivery (CD) in Denmark. Preoperative preparations for CD include the placement of an indwelling urinary catheter. The rationale behind the procedure is to decrease the risk of surgical injury to a distended bladder and to avoid postoperative urinary retention, but the scientific evidence of the benefit to these matters is not compelling(1). On the other hand, the placement of an indwelling urinary catheter poses a considerable risk of urinary tract infection (UTI) (2), besides the costs associated with delayed ambulation, prolonged hospital stay and catheter associated discomfort to the woman (3, 4) A Cochrane review (1) on indwelling bladder catheter versus no catheter inserted at CD, found that indwelling bladder catheterization was associated with longer time to first spontaneous voiding and more pain/discomfort due to catheterization and/or with first voiding. Furthermore, the women with an indwelling catheter had longer time to ambulation and longer hospital stay. None of the included studies (n=3) in the review reported on bladder injury nor the prespecified criteria for diagnosing UTI and thus no result on UTI as a primary outcome could be obtained. In addition, none of the randomized trials on CD with or without an indwelling bladder catheter were carried out in countries with peri-operative procedures and handling of patients similar to those in Europe. In a prospective clinical study (5), there were no bladder injuries in 344 women undergoing elective CD without a catheter. UTI was significantly more prevalent in the catheterized group (6%) than in the non-catheterized group (0.58%), P<0.05). In retrospective studies on women undergoing CD with an indwelling catheter, the overall prevalence of bladder injuries is found to be around 0.3%(6, 7). The aim of this study is to compare the incidence of catheter associated culture- based urinary tract infection (UTI) after elective CD with or without preoperative placement of a urinary catheter. Statistics Sample size: A power calculation was performed based on a 5.7% incidence of UTI in the catheter group and 0.5% in the non-catheter group(4). With an alpha of 0.05 and a power of 80%, a total of 400 women would have to be included to detect a significant difference in the primary outcome. The association between the placement of an indwelling urinary catheter during caesarean delivery and the outcomes of interest will be explored using an Intention-to-treat (ITT) analysis. The investigators will perform comparative analyses using multivariate logistic regression with calculation of Odds Ratios with 95% confidence intervals with adjustments for significant differences in baseline characteristics. Subgroup analyses will be performed according to the number of previous CDs No interim analysis will be performed. A local trial steering committee will be appointed. Side effects, risks, and inconveniences for the project participants Any inconveniences for the women in the study with providing an extra urinary sample for bacterial culture are very small. Women in the indwelling catheter group receive current standard treatment. Women without a catheter may have an increased risk of: 1. Urinary retention; a known side effect to surgical procedures and regional anaesthesia (9, 10). The women without an indwelling catheter might have a slightly increased risk of urinary retention, but with our postoperative surveillance all cases will be detected and treated in both groups of women. 2. Intraoperative bladder injury; the overall risk is very low (0.3%). In women suspected of peri-operative bladder injury, both with or without an indwelling catheter, methylene blue will be installed into the bladder through an indwelling catheter, which will serve to identify the leak. In case of accidental bladder puncture, surgical repair will be performed immediately. On the other hand, women without a catheter may have a decreased risk of 1. Urinary tract infection 2. Delayed ambulation 3. Prolonged hospitalization Information from patient records The participants' medical records are accessed for information on the predefined outcomes; urine test results, any voiding difficulties after CD and catheter removal, information on the surgery, time to ambulation, length of hospital stay, any sign or symptoms of an infection or fever during hospital stay and if there has been any contact to our department after discharge. Legal considerations The project will be reported to the Danish Data Protection Agency through the joint notifications, Region Midtjylland. The information collected from the project participants will be protected according to Danish law (Lov om behandling af personoplysninger and Sundhedsloven). Basic information (name, contact information, social security number, previous medical and pregnancy history) is provided by the participants upon inclusion. Financial compensation The project participants will not receive financial compensation for their participation. Participant information and inclusion Contact to potential participants is established at a joint information meeting for women booked for planned CD, where verbal and written information about the project will be provided, by a project assistant or a midwife from the delivery ward. Both the assistant and midwife are informed and taught personally by the trial doctor. Thus, women will have the opportunity for reflection at least 4 days before making any decision. Furthermore, the women are offered extended verbal information at the delivery ward, where they are welcome to bring an assessor. In any need of further information, the women will be given contact information on key persons responsible for the project. All study participants give oral and written consent at the day of the CD, after at least 4 days of consideration in accordance with the Declaration of Helsinki and Central Denmark Research Ethics Committee. The women are informed that their consent can be withdrawn at any time.

Official TitleCaesarean Delivery With or Without an Indwelling Bladder Catheter
NCT03672214
Principal SponsorUniversity of Aarhus
Study ContactHelle F Bungum, MDMore contacts
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

400 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsInfectionsUrinary Tract InfectionsUrologic DiseasesFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

1 inclusion criteria required to participate
Elective caesarean section.

3 exclusion criteria prevent from participating
Antibiotic therapy during the last week before caesarean section

≥ 3 prior CDs.

Contractions or rupture of membranes.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
No placement of indwelling catheter prior to Caesarean section

Group II

Active Comparator
Placement of indwelling catheter prior to Caesarean section

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

The Regional Hospital of Randers

Randers, DenmarkOpen The Regional Hospital of Randers in Google Maps
SuspendedOne Study Center